Myrexis, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
65/100
80
Valuation
20
Profitability
60
Growth
84
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYRX research report →
52-Week Range12% of range
Low $0.00
Current $0.00
High $0.01
Companywww.myrexis.com
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc.
- CEO
- Jonathan Couchman
- IPO
- 2009
- Employees
- 1
- HQ
- New York City, NY, US
Price Chart
-87.14% · this period
Valuation
- Market Cap
- $31.03K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- 0.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -25.67%
- ROIC
- -1031.04%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-11,621,000 · 62.76%
- EPS
- $-0.39 · 66.95%
- Op Income
- $-11,991,000
- FCF YoY
- 53.39%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 3.35
- Avg Volume
- 504
Get TickerSpark's AI analysis on MYRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 22, 13 | COUCHMAN JONATHAN | other | 0 |
| Jan 18, 13 | HENDERSON JOHN T | other | 2,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
| Jan 18, 13 | HENDERSON JOHN T | other | 7,500 |
Our MYRX Coverage
We haven't published any research on MYRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MYRX Report →Similar Companies
AAPT+0.00%
All American Pet Company, Inc.
$0.00
JADA+0.00%
Jade Art Group Inc.
$0.00
CDSG+14.17%
China Dongsheng International, Inc.
$0.00
TAKD+0.00%
TransAKT Ltd.
$0.00
LTUS+0.00%
Lotus Pharmaceuticals, Inc.
$0.00
CNHC+0.00%
China Health Management Corp.
$0.00
ALDA+0.00%
Atlantica, Inc.
$0.05
WORC+0.00%
Wake Up Now, Inc.
$0.00